Technology
Health
Biotechnology

Vascular Biogenics

$1.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-5.80%) As of 3:24 PM EDT today
-$0.08 (-5.80%) Today

Why Robinhood?

You can buy or sell VBLT and other stocks, options, ETFs, and crypto commission-free!

About VBLT

Vascular Biogenics Ltd. Ordinary Shares, also called Vascular Biogenics, is in the clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of first-in-class treatments for cancer. Read More It offers different programs for cancer and inflammatory disease patients such as vascular targeting system and Lecinoxoids. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.

Employees
Headquarters
Modi'in, Jerusalem
Founded
2000
Market Cap
49.16M
Price-Earnings Ratio
Dividend Yield
Average Volume
51.59K
High Today
$1.39
Low Today
$1.30
Open Price
$1.36
Volume
39.31K
52 Week High
$2.15
52 Week Low
$0.60

Collections

Technology
Health
Biotechnology
Cancer Prevention
Medical
Biopharmaceutical
Pharmaceutical
2014 IPO

VBLT Earnings

-$0.24
-$0.08
$0.08
$0.24
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 15, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.